NordicCan A/S: Financial statements 2019
CVR: 37633925
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
NordicCan A/S (CVR 37633925) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 84,000 and a net result of DKK -52,000 compared with DKK -7,747,000 the year before. Equity in the 2019 report amounted to DKK 1,813,000. The solvency ratio was 40.3%.
- Gross Profit
- DKK 84,000
- Profit/Loss
- DKK -52,000
- Equity
- DKK 1,813,000
- Total Assets
- DKK 4,497,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 84K | -52K | 1.8M | - |
| 2018 | - | -8.3M | -7.7M | 1.9M | 2 |
| 2017 | - | -6K | -7K | 481K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
NordicCan A/S has published its annual report for 2018. Gross profit came to DKK -8,299,000, and the net result was DKK -7,747,000.
As of January 4, 2019, Christopher Beck Lambert has joined the board of directors of NordicCan A/S.
As of January 4, 2019, Michael Henrik Thomsen has joined the board of directors of NordicCan A/S.
As of January 4, 2019, Erik Gregers Hansen has left the board of directors of NordicCan A/S.
As of January 4, 2019, Steen Bagger-Sørensen has left the board of directors of NordicCan A/S.
As of January 4, 2019, Søren Birn is registered as chairman of NordicCan A/S.
As of January 4, 2019, Claus Bagger-Sørensen has stepped down as chairman of NordicCan A/S.
About NordicCan A/S
NordicCan A/S was a Danish company of the type Aktieselskab based in Vejle, founded in 2016. The company has been dissolved on 24 March 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MedCan Pharma A/S. The company has 22 employees (2018). In 2021, the company reported a net result of DKK -4,058,000 compared with DKK -1,987,000 the year before. Equity in the 2021 report amounted to DKK 5,767,000.